Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 1301 - 1400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1301 | 25589981 |
CA |
43 | 2 |
Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Overlap syndrome, Contraindicated product administered, Exposure during pregnancy, Maternal exposure during pregnancy, Off label use, Dyspepsia, Gait inability, Hypercholesterolaemia, Incorrect route of product administration, Lower limb fracture, Oedema, Asthma, Autoimmune disorder, Chest pain, Contusion, Deep vein thrombosis postoperative, Prescribed overdose, Prescribed underdose, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM, CANDESARTAN, CANDESARTAN, RAMIPRIL, CALCIUM CARBONATE, ANTACID, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PANTOPRAZOLE, PANTOPRAZOLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 1302 | 25590057 |
US |
2 | |
Head discomfort, Paraesthesia oral, Paraesthesia, Eye paraesthesia, Dizziness, Product substitution issue, |
||||
DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, |
||||
| 1303 | 25590624 |
CA |
43 | 2 |
Abdominal discomfort, Drug intolerance, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Nail disorder, Walking aid user, Hepatic enzyme, Weight decreased, Product quality issue, Weight fluctuation, Weight increased, Wheezing, Blepharospasm, White blood cell count increased, Wound, Wound infection, Gastrooesophageal reflux disease, X-ray abnormal, Abdominal pain, Abdominal pain upper, Taste disorder, Adjustment disorder with depressed mood, Adverse drug reaction, Musculoskeletal pain, Musculoskeletal stiffness, Myalgia, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Pregnancy, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Protein total increased, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rash pruritic, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Therapeutic product effect decreased, Therapeutic response decreased, Therapy non-responder, Thrombocytopenia, Treatment failure, Type 2 diabetes mellitus, Ulcer haemorrhage, Underdose, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis, Deep vein thrombosis postoperative, Delirium, Depressed mood, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug ineffective for unapproved indication, Drug tolerance decreased, Drug tolerance decreased, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Ear pain, Exostosis, Eye injury, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Foot deformity, Frequent bowel movements, Functional gastrointestinal disorder, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Knee arthroplasty, Laboratory test abnormal, Laryngitis, Leukopenia, Lip dry, Live birth, Liver disorder, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Lupus-like syndrome, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Medication error, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscle spasticity, Muscular weakness, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Antiphospholipid antibodies, Anxiety, Arthralgia, Arthritis, Arthropathy, Aspartate aminotransferase abnormal, Asthenia, Asthma, Autoimmune disorder, Back pain, Blister, Blood cholesterol increased, Body temperature increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Epilepsy, Contraindicated product administered, Adverse event, |
||||
APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT DIMEGLUMINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 1304 | 25590713 |
GB |
70 | 2 |
Glossitis, Muscle spasms, Exophthalmos, Groin pain, Glossodynia, Ear pain, Pain in extremity, Back pain, Tongue erythema, Lymphadenopathy, Musculoskeletal stiffness, Nausea, Fatigue, Neuralgia, Headache, Arthralgia, Pain, Electric shock sensation, Eye pain, Abdominal pain, Urinary retention, Hypersomnia, Dizziness, Paraesthesia, Pollakiuria, Chest pain, Hair growth abnormal, Nail growth abnormal, Onychoclasis, Nail disorder, Joint stiffness, Bone pain, Clumsiness, Disturbance in attention, Feeling hot, Dysphagia, Haemorrhage, Bursitis, Oropharyngeal discolouration, Eye infection, Feeling cold, Pharyngitis, Blepharospasm, Vaccination site swelling, Decreased appetite, Constipation, Feeling abnormal, Memory impairment, Anxiety, Confusional state, Nightmare, Palpitations, Pelvic misalignment, Abnormal loss of weight, Dysgraphia, Heart rate increased, Lip discolouration, Skin discolouration, Nerve compression, Incontinence, Chromaturia, Urine odour abnormal, Ovarian mass, Balance disorder, Hiccups, Oropharyngeal pain, Throat irritation, Rash, Seizure, Hypertension, Hypersensitivity, Sensory disturbance, Lymphadenopathy, Lymph node pain, Fatigue, Dizziness, Mouth haemorrhage, Osteoarthritis, Dyspnoea, Hot flush, Dysuria, Bowel movement irregularity, Psoriasis, |
||||
PREGABALIN, MORPHINE SULFATE, BISOPROLOL FUMARATE, CANDESARTAN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1305 | 25590764 |
EU |
67 | 2 |
Blood pressure systolic increased, Agoraphobia, Paraesthesia, Depression, Tinnitus, Palpitations, Dyspnoea exertional, Nightmare, Panic reaction, |
||||
ROSUVASTATIN, |
||||
| 1306 | 25591091 |
71 | 1 | |
Drug monitoring procedure not performed, Hyperglycaemia, Paraesthesia, Vision blurred, Polyuria, Polydipsia, Blood ketone body, Aspartate aminotransferase increased, Alanine aminotransferase increased, Bundle branch block right, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, |
||||
| 1307 | 25591558 |
US |
44 | 1 |
Vertigo, Paraesthesia, Hypoaesthesia, Migraine, Postural orthostatic tachycardia syndrome, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, LISINOPRIL, LISDEXAMFETAMINE DIMESYLATE, PREDNISONE, CARIPRAZINE, GABAPENTIN, GABAPENTIN, LUBIPROSTONE, DIVALPROEX SODIUM, NALTREXONE HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1308 | 25591923 |
EU |
38 | |
Paraesthesia, Pain, Tension, Formication, Sensitive skin, |
||||
RUXOLITINIB, |
||||
| 1309 | 25592578 |
US |
||
Vision blurred, Dyschromatopsia, Paraesthesia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1310 | 25593035 |
US |
30 | 1 |
Feeling abnormal, Paraesthesia, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1311 | 25593081 |
US |
66 | 2 |
Pruritus, Rash, Neuropathy peripheral, Paraesthesia, Fibromyalgia, Peripheral swelling, Burning sensation, Abdominal pain, |
||||
POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, IXAZOMIB, |
||||
| 1312 | 25593155 |
US |
2 | |
Neuropathy peripheral, Hypoaesthesia, Paraesthesia, Discomfort, Fatigue, Feeling abnormal, Loss of personal independence in daily activities, Nausea, Vomiting, Dysphagia, |
||||
OLAPARIB, |
||||
| 1313 | 25583136 |
GB |
21 | 2 |
Chest discomfort, Paraesthesia, Dizziness, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 1314 | 25583366 |
GB |
68 | 1 |
Scleritis, Symptom recurrence, Rash, Transfusion, Stem cell transplant, Drug ineffective, Pharyngeal swelling, Swollen tongue, Biopsy bone marrow, Dyspnoea, Paraesthesia, Infection, Injection site reaction, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, |
||||
| 1315 | 25583590 |
CA |
||
Surgery, Burning sensation, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1316 | 25583611 |
CA |
41 | 2 |
Anaphylactic reaction, Skin burning sensation, Feeling hot, Nasal congestion, Urticaria, Dizziness, Headache, Dyspnoea, Fatigue, Paraesthesia, Swelling face, Periorbital swelling, Throat clearing, Somnolence, Chest discomfort, Skin tightness, Somatic symptom disorder, |
||||
OMALIZUMAB, NAPROXEN, NAPROXEN SODIUM, HYDROCORTISONE SODIUM SUCCINATE, EPINEPHRINE, ADRENALINUM, |
||||
| 1317 | 25583971 |
US |
41 | 2 |
Hypoaesthesia, Paraesthesia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1318 | 25583985 |
US |
||
Paraesthesia, |
||||
ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 1319 | 25584335 |
CA |
2 | |
Lower respiratory tract infection, Cardiac failure congestive, Lung disorder, Paraesthesia, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1320 | 25584568 |
US |
43 | 1 |
Paraesthesia, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 1321 | 25584800 |
GB |
77 | 1 |
Brain fog, Lymphadenopathy, Gait disturbance, Dyspnoea, Night sweats, Paraesthesia, Dizziness, Fatigue, Nausea, |
||||
PANTOPRAZOLE, |
||||
| 1322 | 25584876 |
US |
||
Alopecia, Arthralgia, Paraesthesia, Hypoaesthesia, Musculoskeletal stiffness, Fatigue, Pain in extremity, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 1323 | 25585013 |
GB |
55 | 1 |
Hypoaesthesia, Pruritus, Paraesthesia, Feeling cold, Headache, |
||||
ETANERCEPT, |
||||
| 1324 | 25585216 |
EU |
25 | 2 |
Cognitive disorder, Drug withdrawal maintenance therapy, Substance dependence, Paraesthesia, |
||||
NITRIC OXIDE, PREGABALIN, |
||||
| 1325 | 25585474 |
GB |
21 | 2 |
Chest discomfort, Dizziness, Paraesthesia, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 1326 | 25586243 |
US |
1 | |
Paraesthesia, |
||||
SUZETRIGINE, |
||||
| 1327 | 25586482 |
US |
62 | 2 |
Hypoaesthesia, Burning sensation, Paraesthesia, Electric shock sensation, Muscular weakness, Clumsiness, Joint swelling, |
||||
TOFACITINIB, |
||||
| 1328 | 25586631 |
EU |
2 | |
Hepatic haematoma, Herpes ophthalmic, Herpes ophthalmic, Leukopenia, Alopecia, Arthralgia, Vulvovaginal pain, Diarrhoea, Asthenia, Rash, Back pain, Paraesthesia, Dyspnoea, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 1329 | 25586729 |
CA |
29 | 2 |
Chest discomfort, Dyspnoea, Fatigue, Head discomfort, Headache, Infusion related reaction, Oropharyngeal discomfort, Paraesthesia, Throat irritation, Off label use, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1330 | 25586732 |
CA |
55 | 2 |
Blood pressure increased, Blood urine present, Condition aggravated, Decreased appetite, Dizziness, Limb mass, Pain in extremity, Paraesthesia, Peripheral swelling, Pollakiuria, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 1331 | 25586804 |
US |
48 | 1 |
Gastrooesophageal reflux disease, Paraesthesia, |
||||
VONOPRAZAN FUMARATE, VONOPRAZAN FUMARATE, |
||||
| 1332 | 25586871 |
US |
55 | 2 |
Hypoaesthesia, Paraesthesia, Dyspnoea, Exercise tolerance decreased, Presyncope, Heart rate increased, |
||||
VONOPRAZAN FUMARATE, |
||||
| 1333 | 25586920 |
US |
51 | 2 |
Paraesthesia, Movement disorder, Pain in extremity, |
||||
VONOPRAZAN FUMARATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
| 1334 | 25586977 |
US |
62 | 2 |
Paraesthesia, Paraesthesia oral, Diaphragmatic spasm, |
||||
VONOPRAZAN FUMARATE, |
||||
| 1335 | 25586980 |
US |
2 | |
Urine output decreased, Paraesthesia, Dizziness, |
||||
VONOPRAZAN FUMARATE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, BENZTROPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 1336 | 25587042 |
US |
2 | |
Paraesthesia, Syncope, Fatigue, |
||||
VONOPRAZAN FUMARATE, |
||||
| 1337 | 25587809 |
EU |
38 | 2 |
Thrombocytopenia, Haemorrhage, Neuropathy peripheral, Breast pain, Asthenia, Cough, Erythema, Paraesthesia, Pruritus, Hyperkalaemia, Headache, Neutropenia, Pyrexia, Tachycardia, Nausea, Myalgia, Constipation, Acne, Hot flush, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 1338 | 25582328 |
US |
2 | |
Diabetes mellitus, Paraesthesia, Muscular weakness, Muscle atrophy, Hypoaesthesia, Weight decreased, |
||||
RAVULIZUMAB, PREDNISONE, |
||||
| 1339 | 25581629 |
CA |
||
Systemic lupus erythematosus, Arthropathy, Blister, Breast cancer stage III, Coeliac disease, Drug intolerance, Drug-induced liver injury, Duodenal ulcer perforation, Epilepsy, Hepatitis, Joint range of motion decreased, Lip dry, Liver injury, Migraine, Muscular weakness, Pemphigus, Pericarditis, Psoriatic arthropathy, Rheumatic fever, Rheumatoid arthritis, Hypoaesthesia, Stomatitis, Dizziness, Injection site reaction, Lower respiratory tract infection, Paraesthesia, Fatigue, Helicobacter infection, Nasopharyngitis, Pneumonia, Live birth, Off label use, Contraindicated product administered, Drug ineffective, Intentional product use issue, Underdose, Overdose, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 1340 | 25581711 |
US |
||
Product administered at inappropriate site, Paraesthesia, Pruritus, |
||||
NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 1341 | 25581767 |
GB |
42 | |
Premature ageing, Vitreous detachment, Chronic fatigue syndrome, Postural orthostatic tachycardia syndrome, Hyporeflexia, Costochondritis, Asthenia, Pain in extremity, Hypoaesthesia oral, Depersonalisation/derealisation disorder, Decreased appetite, Insomnia, Anxiety, Panic attack, Depression, Paraesthesia, Muscular weakness, Tendon pain, Chest discomfort, Headache, Fear of death, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 1342 | 25582080 |
EU |
29 | 2 |
Deafness unilateral, Paraesthesia, |
||||
FREMANEZUMAB-VFRM, MIRTAZAPINE, |
||||
| 1343 | 25582127 |
AU |
36 | 1 |
Burning sensation, Gait disturbance, Muscular weakness, Myalgia, Paraesthesia, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 1344 | 25582132 |
AU |
40 | 2 |
Anaphylactic reaction, Cold sweat, Flushing, Nausea, Paraesthesia, Urticaria, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREGABALIN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 1345 | 25574653 |
EU |
70 | 1 |
Rash erythematous, Paraesthesia, Blister, Pruritus, |
||||
ALLOPURINOL, |
||||
| 1346 | 25574969 |
US |
23 | 2 |
Blood pressure decreased, Syncope, Dizziness, Paraesthesia, Feeling hot, |
||||
LUMATEPERONE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 1347 | 25575019 |
US |
67 | 2 |
Paraesthesia, |
||||
OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, LEVOTHYROXINE, |
||||
| 1348 | 25575246 |
US |
||
Paraesthesia, Exercise tolerance decreased, Dizziness, Fatigue, Hot flush, Blood glucose increased, Hyperhidrosis, Headache, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 1349 | 25575470 |
CA |
43 | 2 |
Migraine, Taste disorder, Vomiting, Sleep disorder, Sleep disorder due to a general medical condition, Abdominal pain upper, Blepharospasm, Drug ineffective, Drug intolerance, Epilepsy, Gastrooesophageal reflux disease, Hypoaesthesia, Memory impairment, Paraesthesia, Off label use, Pain, Product use in unapproved indication, Rash, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Stomatitis, Swelling, Swollen joint count increased, Synovitis, |
||||
ONABOTULINUMTOXINA, LEVOMILNACIPRAN HYDROCHLORIDE, |
||||
| 1350 | 25575572 |
EU |
49 | 2 |
Tremor, Vomiting, Paraesthesia, Feeling cold, |
||||
TRASTUZUMAB-ANNS, TRASTUZUMAB-ANNS, DOCETAXEL, DOCETAXEL ANHYDROUS, PERTUZUMAB, |
||||
| 1351 | 25575587 |
CA |
52 | 1 |
Atrial fibrillation, Hyperthyroidism, Hypothyroidism, Fatigue, Dizziness, Paraesthesia, Weight increased, Gingival pain, Pruritus, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, PEMBROLIZUMAB, METHIMAZOLE, ATENOLOL, |
||||
| 1352 | 25575660 |
US |
69 | 1 |
Gingival abscess, Paraesthesia, Incorrect dose administered, |
||||
RELUGOLIX, GLIMEPIRIDE, SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DAROLUTAMIDE, ERGOCALCIFEROL, RIVAROXABAN, RAMIPRIL, |
||||
| 1353 | 25575843 |
EU |
81 | 1 |
Paraesthesia, Dysentery, |
||||
CAPECITABINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 1354 | 25575935 |
US |
55 | 2 |
Blood pressure increased, Facial pain, Headache, Vision blurred, Dry eye, Lacrimation increased, Paraesthesia, |
||||
MIRVETUXIMAB SORAVTANSINE, |
||||
| 1355 | 25576630 |
CA |
75 | 1 |
Lung disorder, Cardiac failure congestive, Chronic obstructive pulmonary disease, Dyspnoea, Full blood count abnormal, Loss of personal independence in daily activities, Asthma, Muscle spasms, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Tachycardia, Therapeutic product effect incomplete, Therapeutic response shortened, Wheezing, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, BENRALIZUMAB, BUDESONIDE, BUPRENORPHINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ROFLUMILAST, DEXLANSOPRAZOLE, DUPILUMAB, GABAPENTIN ENACARBIL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MOMETASONE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREGABALIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, GLYCOPYRROLATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, THEOPHYLLINE, |
||||
| 1356 | 25576743 |
GB |
2 | |
Swelling face, Skin exfoliation, Condition aggravated, Erythema, Paraesthesia, Skin irritation, |
||||
| 1357 | 25576840 |
CA |
60 | 1 |
Transitional cell carcinoma metastatic, Malignant neoplasm progression, Fatigue, Kidney infection, Neuropathy peripheral, Sinus congestion, Blood pressure fluctuation, Paraesthesia, Hypoaesthesia, Alopecia, Dry mouth, Nausea, Dry eye, Pruritus, Rash, Stoma site haemorrhage, Blood pressure increased, Blood pressure systolic increased, Palmar-plantar erythrodysaesthesia syndrome, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PEMBROLIZUMAB, DIMENHYDRINATE, DIMENHYDRINATE, EPINEPHRINE, ADRENALINUM, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1358 | 25576849 |
CA |
57 | 2 |
Pruritus, Sneezing, Nasal congestion, Hypertension, Paraesthesia, Condition aggravated, Rhinorrhoea, Chest discomfort, Throat irritation, Wheezing, COVID-19, Seasonal allergy, Anaphylactic reaction, Swollen tongue, Eye swelling, Dyspnoea, Urticaria, Middle insomnia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1359 | 25576925 |
US |
||
Paraesthesia, |
||||
RELUGOLIX, RELUGOLIX, AMLODIPINE, CARVEDILOL, SACUBITRIL AND VALSARTAN, EPLERENONE, GABAPENTIN, GLIPIZIDE, HYDRALAZINE HYDROCHLORIDE, MAGNESIUM OXIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PRAVASTATIN SODIUM, |
||||
| 1360 | 25577076 |
GB |
84 | 2 |
Paraesthesia, Gastrooesophageal reflux disease, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, BISOPROLOL FUMARATE, LOSARTAN, CLARITHROMYCIN, SENNOSIDES, SENNA LEAF, SENNA, NITROGLYCERIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, GABAPENTIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BUPRENORPHINE, FUROSEMIDE, SIMVASTATIN, |
||||
| 1361 | 25577147 |
TW |
50 | 2 |
Rash pruritic, Rash erythematous, Pruritus, Erythema, Swelling, Dyspnoea, Paraesthesia, Cough, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, VINORELBINE, VINORELBINE, VINORELBINE, VINORELBINE, VINORELBINE, |
||||
| 1362 | 25577396 |
US |
55 | 2 |
Paraesthesia, |
||||
DUPILUMAB, |
||||
| 1363 | 25577503 |
US |
2 | |
Neuropathy peripheral, Deafness, Paraesthesia, Joint instability, Balance disorder, Ear discomfort, Fatigue, Fall, Unevaluable event, |
||||
DICHLORPHENAMIDE, DICHLORPHENAMIDE, |
||||
| 1364 | 25577571 |
US |
67 | 2 |
Paraesthesia, |
||||
ORAL SEMAGLUTIDE, |
||||
| 1365 | 25577588 |
CA |
37 | 2 |
Ear pruritus, Erythema, Herpes zoster, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Paraesthesia, Pharyngeal swelling, Productive cough, Rash, Rash erythematous, Throat irritation, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 1366 | 25577829 |
US |
2 | |
Paraesthesia, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 1367 | 25578042 |
US |
65 | 1 |
Rash, Paraesthesia, Gastrointestinal disorder, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1368 | 25578188 |
EU |
42 | 2 |
Neuropathy peripheral, Neuropathy peripheral, Muscle spasms, Peripheral sensory neuropathy, Muscular weakness, Tachycardia, Nausea, Dysarthria, Dysphagia, Paraesthesia, |
||||
OXALIPLATIN, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 1369 | 25578331 |
US |
38 | 2 |
Hypoaesthesia, Paraesthesia, Pain, |
||||
RIMEGEPANT SULFATE, |
||||
| 1370 | 25578983 |
US |
||
Temperature intolerance, Fatigue, Paraesthesia, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 1371 | 25578991 |
ZA |
63 | |
Hypertension, Paraesthesia, Headache, |
||||
| 1372 | 25579227 |
US |
35 | 2 |
Neuropathy peripheral, Myalgia, Muscle twitching, Muscle spasms, Nausea, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1373 | 25579341 |
US |
52 | 1 |
Hypoaesthesia, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1374 | 25579644 |
US |
45 | 2 |
Myalgia, Arthralgia, Paraesthesia, Skin burning sensation, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1375 | 25579651 |
CA |
2 | |
Pulmonary sarcoidosis, Lung operation, Fatigue, Abdominal pain upper, Cough, Paraesthesia, Restless legs syndrome, Product use in unapproved indication, Intentional dose omission, |
||||
CERTOLIZUMAB PEGOL, LEFLUNOMIDE, TELMISARTAN, HYDROCHLOROTHIAZIDE, LINACLOTIDE, PANTOPRAZOLE, ALBUTEROL SULFATE, |
||||
| 1376 | 25579688 |
US |
62 | 2 |
Skin irritation, Skin burning sensation, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1377 | 25579690 |
US |
44 | 2 |
Adverse drug reaction, Injection site pain, Weight increased, Frequent bowel movements, Nausea, Constipation, Vertigo, Dizziness, Headache, Paraesthesia, Temperature intolerance, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, PROCHLORPERAZINE, ONABOTULINUMTOXINA, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, FREMANEZUMAB-VFRM, EPINEPHRINE, ADRENALINUM, AZELASTINE, FAMOTIDINE, OLOPATADINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, DIVALPROEX SODIUM, CICLESONIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, EPINEPHRINE, ADRENALINUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 1378 | 25579917 |
US |
2 | |
Back pain, Paraesthesia, Therapeutic product effect decreased, Product dispensing error, Inappropriate schedule of product administration, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1379 | 25579925 |
US |
2 | |
Hypoaesthesia, Hypoaesthesia, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1380 | 25580151 |
US |
2 | |
Hunger, Paraesthesia, Drug ineffective, |
||||
SEMAGLUTIDE, |
||||
| 1381 | 25580347 |
US |
2 | |
Palpitations, Insomnia, Paraesthesia, Injection site indentation, |
||||
SEMAGLUTIDE, |
||||
| 1382 | 25580391 |
CA |
44 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Antiphospholipid antibodies, Anxiety, Arthralgia, Arthritis, Arthropathy, Aspartate aminotransferase abnormal, Asthenia, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Chest pain, Colitis ulcerative, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depressed mood, Depression, Discomfort, Dislocation of vertebra, Drug tolerance decreased, Duodenal ulcer perforation, Dyspnoea, Ear infection, Exostosis, Feeling hot, Folliculitis, Foot deformity, Functional gastrointestinal disorder, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Impaired healing, Insomnia, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema peripheral, Osteoarthritis, Osteoporosis, Pancreatitis, Paraesthesia, Peripheral swelling, Porphyria acute, Protein total increased, Pruritus, Pyrexia, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Retinitis, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Visual impairment, Weight decreased, Weight increased, White blood cell count increased, Wound infection, Abdominal pain, Asthma, Confusional state, Fatigue, Glossodynia, Helicobacter infection, Hypersensitivity, Ill-defined disorder, Live birth, Wound, Irritable bowel syndrome, Joint range of motion decreased, Liver function test increased, Liver injury, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Pneumonia, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Rash, Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sinusitis, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Vomiting, Wheezing, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Pregnancy, Exposure during pregnancy, Prescribed overdose, Product use issue, Therapy non-responder, Treatment failure, Prescribed underdose, Underdose, |
||||
MESALAMINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, RAMIPRIL, CAFFEINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, PREDNISONE, PREDNISONE, HYALURONIDASE, MORPHINE, LANSOPRAZOLE, RITUXIMAB, RITUXIMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, |
||||
| 1383 | 25580473 |
US |
68 | 2 |
Pain, Piloerection, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 1384 | 25580660 |
US |
||
Panic reaction, Abdominal distension, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1385 | 25580968 |
US |
2 | |
Anxiety, Paraesthesia, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 1386 | 25581273 |
US |
2 | |
Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1387 | 25581293 |
US |
41 | 2 |
Hypoaesthesia, Pain of skin, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1388 | 25581330 |
US |
2 | |
Hypoaesthesia, Paraesthesia, Diarrhoea, |
||||
SEMAGLUTIDE, |
||||
| 1389 | 25581389 |
US |
31 | 2 |
Skin reaction, Paraesthesia, Sensitive skin, Burning sensation, |
||||
SEMAGLUTIDE, |
||||
| 1390 | 25581441 |
US |
1 | |
Neuralgia, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 1391 | 25585031 |
|||
Paraesthesia, Nausea, Feeling hot, Infusion related reaction, |
||||
| 1392 | 25585036 |
2 | ||
Dizziness, Flushing, Constipation, Nightmare, Tinnitus, Therapy cessation, Heart rate increased, Paraesthesia, Dry mouth, Presyncope, Atrial fibrillation, |
||||
AMITRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, |
||||
| 1393 | 25585280 |
29 | 2 | |
Tendon pain, Back pain, Paraesthesia, Burning sensation, Burning sensation, Burning sensation, Feeling abnormal, Depressed mood, Suicidal ideation, Insomnia, Anxiety, Depression, Nervousness, Brain fog, Memory impairment, Disturbance in attention, Night sweats, Body temperature abnormal, Paraesthesia, Tremor, Tremor, |
||||
CIPROFLOXACIN HYDROCHLORIDE, ESCITALOPRAM, IRON, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 1394 | 25569899 |
US |
55 | 2 |
Neuropathy peripheral, Neuropathy peripheral, Emphysema, Coronary artery disease, Palpitations, Insomnia, Malaise, Paraesthesia, Feeling jittery, Feeling abnormal, Fatigue, Pain, Neck pain, Back pain, Pain, Sensitive skin, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 1395 | 25569950 |
US |
2 | |
Multiple sclerosis, Prescribed underdose, Inappropriate schedule of product administration, Rash papular, Cutaneous symptom, Pain in extremity, Feeling of body temperature change, Lip pain, Oropharyngeal pain, Headache, Neck pain, Hypoaesthesia, Paraesthesia, Sensory disturbance, Pruritus, Flushing, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, LISINOPRIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, |
||||
| 1396 | 25569969 |
US |
67 | 2 |
Groin pain, Food intolerance, Lymphadenopathy, Paraesthesia, Nasopharyngitis, Sinus headache, Abdominal pain upper, |
||||
TIRZEPATIDE, |
||||
| 1397 | 25570014 |
US |
25 | 2 |
Deafness, Abdominal pain, Hypertransaminasaemia, Iron overload, Malaise, Fatigue, Vision blurred, Temperature intolerance, Diarrhoea, Dyspepsia, Nausea, Rash, Asthenia, Insomnia, Blood glucose increased, Aspartate aminotransferase increased, Dizziness, Malaise, Ear pain, Sinus pain, Tinnitus, Ocular hyperaemia, Palpitations, Paraesthesia, Headache, Mean cell volume increased, Alanine aminotransferase increased, Haematocrit increased, Mean cell volume increased, Lymphocyte count increased, Monocyte count increased, Carbon dioxide increased, |
||||
ASFOTASE ALFA, |
||||
| 1398 | 25570093 |
CA |
||
Blood pressure systolic decreased, Body temperature decreased, Choking, Choking sensation, Dysphagia, Eye oedema, Eye swelling, Face oedema, Fall, Fracture, Heart rate decreased, Hypoaesthesia, Muscle tightness, Upper limb fracture, Paraesthesia, Weight increased, Throat tightness, Lip swelling, Dyspnoea, Angioedema, Cough, Hypertension, Oropharyngeal pain, Pain, Rhinorrhoea, Swelling, Swelling face, Urticaria, Headache, Nasopharyngitis, Sinusitis, Therapeutic product effect decreased, Therapeutic response shortened, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, BISOPROLOL FUMARATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 1399 | 25570135 |
CA |
||
Acne, Asthenia, Chronic spontaneous urticaria, Discomfort, Erythema, Feeling hot, Heart rate increased, Insomnia, Pain, Papule, Paraesthesia, Pigmentation disorder, Pruritus, Rash, Scratch, Skin injury, Skin lesion, Skin plaque, Stress, Urticaria, Burning sensation, Herpes zoster, Off label use, Therapy partial responder, Drug ineffective, Intentional product use issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LEVOTHYROXINE SODIUM, |
||||
| 1400 | 25570348 |
CA |
42 | 2 |
Angina pectoris, Dyspnoea, Hernia, Intervertebral disc protrusion, Malaise, Mobility decreased, Paraesthesia, Peripheral swelling, Polymyalgia rheumatica, Skin plaque, Somnolence, Symptom recurrence, Systemic lupus erythematosus, Tachycardia, Pain, Therapeutic product effect decreased, Product dose omission issue, |
||||
BELIMUMAB, BELIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, PREDNISONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
